| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Grace Lai-Hung Wong | Q38136022 |
| P2093 | author name string | Vicnent Wai-Sun Wong | |
| Wendell Zaragoza Espinosa | |||
| P2860 | cites work | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q21534928 |
| Management of hepatocellular carcinoma: An update | Q27860530 | ||
| Global epidemiology of hepatitis C virus infection | Q27860799 | ||
| Hepatocellular carcinoma | Q29615765 | ||
| Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study | Q30418856 | ||
| Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma | Q30479629 | ||
| Non-invasive predictors of esophageous varices in children and adolescents with chronic liver disease or extrahepatic portal venous obstruction. | Q33402935 | ||
| Predictors of esophageal varices in patients with HBV-related cirrhosis: a retrospective study | Q33406027 | ||
| FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy | Q34686484 | ||
| Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis | Q34690306 | ||
| Non-invasive predictors of esophageal varices | Q34996109 | ||
| Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis | Q35595906 | ||
| Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease | Q36014015 | ||
| Renovascular impedance correlates with portal pressure in patients with liver cirrhosis | Q36519644 | ||
| Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy. | Q37241565 | ||
| Transient elastography | Q37805637 | ||
| Natural history of cirrhosis. | Q38073661 | ||
| Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection? | Q38508865 | ||
| Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables | Q38995179 | ||
| Can serum fibrosis markers predict medium/large oesophageal varices in patients with liver cirrhosis? | Q39015654 | ||
| Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. | Q39332284 | ||
| Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices | Q39506682 | ||
| Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. | Q39896037 | ||
| Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study | Q41073361 | ||
| Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model | Q42122754 | ||
| Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients. | Q42175529 | ||
| Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test. | Q42198890 | ||
| Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®). | Q42206592 | ||
| Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C. | Q42237621 | ||
| Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®). | Q42238599 | ||
| On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir | Q42262667 | ||
| Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease | Q87406034 | ||
| Hepatitis B virus infection | Q88131866 | ||
| Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis | Q42272167 | ||
| Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study. | Q42975904 | ||
| Exceeding the limits of liver histology markers | Q43185946 | ||
| Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus | Q43419593 | ||
| Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease. | Q43711719 | ||
| A validated clinical tool for the prediction of varices in PBC: the Newcastle Varices in PBC Score. | Q43836239 | ||
| Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis | Q43894938 | ||
| Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. | Q43973491 | ||
| Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis | Q44373698 | ||
| Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography | Q45055754 | ||
| Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). | Q45369097 | ||
| Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography | Q45387913 | ||
| Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. | Q45392148 | ||
| Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores | Q46242740 | ||
| Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation. | Q46367959 | ||
| Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. | Q46427719 | ||
| Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients. | Q50590328 | ||
| Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension. | Q50953039 | ||
| Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. | Q51103890 | ||
| Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B. | Q51139539 | ||
| Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. | Q51444679 | ||
| Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study | Q51541188 | ||
| Hepatic venous pressure gradients measured by duplex ultrasound. | Q51541412 | ||
| On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. | Q51584406 | ||
| Alcoholic liver disease. | Q51764048 | ||
| Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. | Q51830742 | ||
| Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis. | Q53028105 | ||
| Hirschsprung's disease with impending abdominal compartment syndrome. | Q53330989 | ||
| Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study. | Q53562811 | ||
| Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. | Q53592212 | ||
| Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure | Q56984918 | ||
| EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis | Q57782665 | ||
| Expanding consensus in portal hypertension | Q58034372 | ||
| Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis | Q58622597 | ||
| Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study | Q58622734 | ||
| Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography | Q61567953 | ||
| Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis | Q61763027 | ||
| The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD | Q61989968 | ||
| Portal pressure, presence of gastroesophageal varices and variceal bleeding | Q69868227 | ||
| Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study | Q70770014 | ||
| Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-color-Doppler | Q74284271 | ||
| Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure | Q77355537 | ||
| [The value of Doppler-ultrasonography and laboratory tests as non-invasive predictors of the presence of esophageal varices in patients with chronic liver disease] | Q79261327 | ||
| Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation | Q79846807 | ||
| Serological surveillance for hepatocellular carcinoma: time to quit | Q83037072 | ||
| Platelet count/spleen diameter ratio for non-invasive diagnosis of oesophageal varices: is it useful in compensated cirrhosis? | Q83415729 | ||
| Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study | Q83482709 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver cirrhosis | Q147778 |
| elasticity imaging techniques | Q72392724 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 200-211 | |
| P577 | publication date | 2015-09-01 | |
| 2015-09-30 | |||
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | Personalized management of cirrhosis by non-invasive tests of liver fibrosis | |
| P478 | volume | 21 |
| Q30357224 | 2-dimensional shear wave elastography: Interobserver agreement and factors related to interobserver discrepancy. |
| Q38683990 | Application of Ultrasound Elastography for Chronic Allograft Dysfunction in Kidney Transplantation. |
| Q42355009 | Can Magnetic Resonance Elastography Fill a Niche in the Market for Noninvasive Assessment of Liver Fibrosis? |
| Q47630903 | Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B. |
| Q88136988 | How many times should we repeat measuring liver stiffness using shear wave elastography?: 5-repetition versus 10-repetition protocols |
| Q39210299 | Invasive and non-invasive assessment of portal hypertension. |
| Q64276062 | Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status |
| Q47550875 | Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend |
| Q40172883 | Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia. |
| Q30375396 | Prospective Comparison of Liver Stiffness Measurements between Two Point Shear Wave Elastography Methods: Virtual Touch Quantification and Elastography Point Quantification. |
| Q38948862 | Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis. |
| Q36993037 | Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B |
| Q53675583 | Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation. |
| Q60310078 | Validation of modified fibrosis-4 index for predicting hepatocellular carcinoma in patients with compensated alcoholic liver cirrhosis |
Search more.